How Much Does Trulicity (Dulaglutide) Cost in Florida in 2026?

Brand-Name Trulicity Pricing in Florida

The wholesale acquisition cost (WAC) for Trulicity is $931 per month in 2026, and Florida retail pharmacies generally charge at or near this price for uninsured cash-pay patients [1]. This price applies to all four dose strengths (0.75 mg, 1.5 mg, 3.0 mg, and 4.5 mg) because Eli Lilly packages each as a carton of four single-dose pens covering one month of once-weekly injections.

Florida ranks among the states with the highest out-of-pocket GLP-1 receptor agonist costs for uninsured residents, largely because the state has not expanded Medicaid under the Affordable Care Act to cover all low-income adults. The result: roughly 2.5 million uninsured Floridians face full list price if they lack employer-sponsored or marketplace coverage [2]. Prices at individual pharmacies may vary by $20 to $80 depending on the chain, but no Florida retailer consistently stocks Trulicity below $850 without a discount program or coupon.

Dulaglutide earned FDA approval in 2014 for glycemic control in type 2 diabetes and received a supplemental indication in 2020 for reduction of major adverse cardiovascular events (MACE) in adults with type 2 diabetes and established or multiple cardiovascular risk factors [3]. The REWIND trial (N=9,901) demonstrated a 12% relative risk reduction in the composite MACE endpoint (HR 0.88 to 95% CI 0.79 to 0.99; P=0.026) over a median follow-up of 5.4 years [4]. That cardiovascular benefit underpins its formulary positioning by many Florida insurers, though coverage terms differ widely.

Florida Medicaid and Trulicity Coverage

Florida Medicaid does not cover Trulicity for type 2 diabetes as of 2026. The state's Medicaid preferred drug list (PDL) excludes dulaglutide from its GLP-1 receptor agonist tier, favoring lower-cost alternatives in the same class.

This exclusion affects over 5 million Florida Medicaid enrollees [5]. Patients who have tried and failed preferred agents may request a prior authorization exception, but approval rates for non-preferred GLP-1 RAs on Florida Medicaid remain low. The Florida Agency for Health Care Administration (AHCA) reviews the PDL quarterly, and dulaglutide has remained off the preferred list since 2024.

For Medicaid-enrolled patients whose physicians believe dulaglutide is medically necessary, the step-therapy pathway typically requires documented failure of or contraindication to at least one preferred GLP-1 RA. "Failure" in this context means inadequate A1C reduction (generally defined as not reaching target after 90 days at maximum tolerated dose) or intolerable side effects confirmed in the medical record.

The American Diabetes Association's 2024 Standards of Care recommend GLP-1 receptor agonists with proven cardiovascular benefit as preferred second-line therapy for patients with type 2 diabetes and established atherosclerotic cardiovascular disease [6]. Dr. Robert Gabbay, ADA Chief Scientific and Medical Officer, has stated: "For patients with type 2 diabetes who have or are at high risk for cardiovascular disease, GLP-1 receptor agonists with proven CV benefit should be part of the glucose-lowering regimen independent of A1C" [6].

Commercial Insurance Coverage in Florida

Most large commercial insurers in Florida cover Trulicity, though formulary tier placement and cost-sharing vary. Patients with employer-sponsored PPO or HMO plans typically pay between $30 and $150 per month after meeting their deductible, depending on whether dulaglutide sits on a preferred or non-preferred specialty tier.

Florida Blue, the state's largest insurer by enrollment, lists Trulicity on its formulary but requires prior authorization confirming a type 2 diabetes diagnosis and trial of metformin (unless contraindicated). Aetna and UnitedHealthcare plans sold in Florida generally place dulaglutide on Tier 3 (non-preferred brand), which carries higher copays than Tier 2. Cigna Florida plans vary by employer group but often require step therapy through metformin and a sulfonylurea or SGLT2 inhibitor before approving a GLP-1 RA.

Marketplace (ACA exchange) plans in Florida present a different picture. Many silver- and bronze-tier plans on the federal marketplace carry high deductibles ($3,000 to $7,000), meaning patients pay full price until they hit that threshold. Once the deductible is met, coinsurance of 20% to 40% on a $931 drug still leaves a monthly bill of $186 to $372. Patients with gold-tier plans or cost-sharing reductions fare better, with typical copays of $50 to $100 per fill.

A practical tip: before filling at any Florida pharmacy, call your insurer's pharmacy benefit line and ask three specific questions. What tier is dulaglutide on? Is prior authorization required? Does the Eli Lilly savings card apply as a secondary discount after my copay?

The Eli Lilly Savings Card: How It Works in Florida

Eli Lilly's Trulicity Savings Card reduces out-of-pocket costs to as little as $25 per month for eligible commercially insured patients. The card is accepted at all major Florida pharmacy chains including CVS, Walgreens, Publix, and Walmart.

Eligibility requirements are straightforward. You must have commercial insurance (not Medicare, Medicaid, Tricare, or any other government-funded plan). You must have a valid prescription for Trulicity. The card covers up to $150 off each monthly fill, with a maximum annual benefit that Eli Lilly adjusts periodically [7].

Here is how the savings card interacts with insurance in a typical Florida scenario. Suppose your plan charges a $75 copay for Trulicity after prior authorization approval. The Lilly savings card reduces that $75 to $25, saving you $50 per fill. If your plan charges $200 in coinsurance, the card brings it down to $50 (the card covers $150). The card does not apply to the deductible phase for most plans, meaning you still pay full price until your deductible is met, though the card payment may count toward your deductible depending on your plan's accumulator policy.

Accumulator adjustment programs complicate this. Some Florida insurers, including certain Aetna and UnitedHealthcare plan designs, use "copay accumulator" programs that prevent manufacturer card payments from counting toward your annual deductible or out-of-pocket maximum [8]. If your plan uses an accumulator, the savings card still lowers your immediate cost but does not help you reach your deductible faster. Ask your benefits coordinator whether your plan uses a copay accumulator before budgeting your annual drug spend.

Compounded Dulaglutide in Florida: Legality and Access

Compounded dulaglutide is available in Florida through licensed 503A compounding pharmacies. These pharmacies operate under the oversight of the Florida Board of Pharmacy and must comply with both state compounding regulations and the Federal Food, Drug, and Cosmetic Act section 503A requirements [9].

A 503A pharmacy compounds medications based on individual patient prescriptions. The prescriber must write a patient-specific prescription, and the pharmacy must source pharmaceutical-grade dulaglutide active ingredient from an FDA-registered supplier. Florida's Board of Pharmacy conducts inspections of 503A facilities and requires compliance with United States Pharmacopeia (USP) chapters 795 and 797 for non-sterile and sterile compounding, respectively.

Pricing for compounded dulaglutide through Florida 503A pharmacies varies, but some patients report costs significantly below the $931 brand-name price. The actual price depends on the compounding pharmacy's sourcing costs, preparation complexity, and dispensing fees. Patients should confirm that any compounding pharmacy they use holds a current Florida pharmacy permit and verify the pharmacy's inspection history through the Florida Department of Health license verification portal.

The FDA's position on compounding GLP-1 receptor agonists has drawn attention nationally. The agency maintains that compounded drugs are not FDA-approved and do not undergo the same safety, efficacy, and manufacturing review as commercially available products [10]. Dr. Janet Woodcock, former FDA Principal Deputy Commissioner, noted in 2023 guidance that "patients and prescribers should understand that compounded drugs carry different risk profiles than their FDA-approved counterparts." Patients considering compounded dulaglutide should discuss these distinctions with their prescribing physician.

Telehealth Prescribing of Trulicity in Florida

Florida law permits telehealth prescribing of Trulicity. Board-certified physicians, nurse practitioners, and physician assistants licensed in Florida can evaluate patients via synchronous audio-video telehealth and prescribe dulaglutide without an in-person visit.

Florida's telehealth statute (Florida Statute 456.47) establishes the legal framework for prescribing controlled and non-controlled substances via telehealth [11]. Dulaglutide is not a controlled substance, which simplifies the prescribing process. The prescriber must establish a valid patient-provider relationship through the telehealth encounter, document the clinical evaluation, and ensure appropriate follow-up.

Several telehealth platforms operating in Florida offer GLP-1 receptor agonist prescribing as part of weight management or diabetes care programs. Costs for telehealth consultations in Florida typically range from $50 to $200 per visit, with some platforms offering monthly subscription models that include the consultation, prescription management, and ongoing monitoring. The telehealth visit fee is separate from the medication cost.

For patients with type 2 diabetes seeking Trulicity through telehealth, the prescriber will typically review recent lab work (A1C, fasting glucose, renal function), current medications, and cardiovascular risk factors before prescribing. The 2024 ADA Standards of Care support the use of telemedicine for diabetes management, noting that "telehealth visits can be as effective as in-person visits for medication management and A1C improvement in many patients with type 2 diabetes" [6].

Discount Programs and Patient Assistance Beyond the Savings Card

Beyond the Eli Lilly savings card, several programs can reduce Trulicity costs for Florida residents. The Lilly Cares Foundation Patient Assistance Program provides free Trulicity to qualifying uninsured or underinsured patients with household incomes at or below 400% of the federal poverty level [7].

Application requires proof of income, a completed prescription from a licensed provider, and documentation showing lack of adequate prescription drug coverage. Processing takes two to four weeks. If approved, the program ships Trulicity directly to the patient's home or prescriber's office at no charge. Reapplication is required annually.

GoodRx, RxSaver, and similar pharmacy discount aggregators occasionally list Trulicity at $820 to $900 at select Florida pharmacies. These discounts are modest relative to the list price but may help uninsured patients shave $30 to $110 per fill. These coupons cannot be combined with insurance or the Lilly savings card.

For Medicare Part D enrollees in Florida, the Inflation Reduction Act's $2,000 annual out-of-pocket cap on prescription drugs (effective 2025) changes the math significantly [12]. A Medicare patient filling Trulicity at $931 per month would hit the $2,000 cap within roughly two to three months, after which they pay nothing for the remainder of the calendar year. This provision applies to all Medicare Part D plans sold in Florida, including Medicare Advantage plans with integrated Part D coverage.

Clinical Value of Dulaglutide: Is the Cost Justified?

Dulaglutide's clinical evidence base supports its use in specific patient populations. The REWIND trial enrolled 9,901 participants with type 2 diabetes (mean age 66.2 years, 31% with prior cardiovascular events) and found that dulaglutide 1.5 mg weekly reduced the composite MACE endpoint by 12% compared to placebo (HR 0.88; P=0.026) over 5.4 years of median follow-up [4]. The trial also demonstrated a mean A1C reduction of 0.61% from a baseline of 7.3%.

The AWARD trial program, which compared dulaglutide head-to-head against multiple diabetes medications, showed A1C reductions of 0.78% to 1.64% depending on dose and comparator [3]. In AWARD-6, dulaglutide 1.5 mg was noninferior to liraglutide 1.8 mg daily for A1C reduction at 26 weeks (both approximately -1.4% from baseline) [13].

Cost-effectiveness analyses have produced mixed conclusions. A 2020 analysis published in Diabetes Care estimated the incremental cost-effectiveness ratio (ICER) of dulaglutide versus standard care at approximately $73,000 per quality-adjusted life year (QALY) for patients with type 2 diabetes and high cardiovascular risk [14]. The Institute for Clinical and Economic Review (ICER) generally considers therapies cost-effective below $100,000 to $150,000 per QALY, placing dulaglutide within a commonly accepted range for this population.

For patients without cardiovascular disease or significant cardiovascular risk factors, the cost-benefit calculation shifts. Generic metformin at $4 to $10 per month and generic SGLT2 inhibitors (where available) offer substantially lower cost entry points. The ADA recommends reserving GLP-1 RAs with cardiovascular benefit specifically for patients who need that protection, not as first-line therapy for all type 2 diabetes patients [6].

Step-by-Step: Getting the Lowest Trulicity Price in Florida

Start with insurance verification. Call the member services number on the back of your insurance card and confirm whether dulaglutide requires prior authorization, what tier it occupies, and your expected copay or coinsurance. Write down the reference number for this call.

If you have commercial insurance, enroll in the Eli Lilly Savings Card program at the manufacturer's website before your first fill. Bring the savings card to the pharmacy alongside your insurance card. The pharmacist runs insurance first, then applies the savings card to the remaining copay.

If you are uninsured and earn below 400% of the federal poverty level ($62,400 for a single individual in 2026), apply to the Lilly Cares Patient Assistance Program. Your prescriber's office can help with the application.

If you are on Medicare Part D, calculate whether you will hit the $2,000 annual out-of-pocket cap quickly enough that paying full price for two to three months is manageable. Some patients front-load their specialty drug fills in January to pass through the cap early and pay nothing for the remaining months.

If you are exploring compounded dulaglutide, verify the pharmacy's Florida license status, confirm USP 797 compliance for sterile preparations, and discuss the FDA's position on compounded biologics with your prescriber before switching from the brand-name product.